d-alpha tocopherol has been researched along with telmisartan in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Al-amran, FG; Ali, SJ; Hadi, N; Huntei, NK; Mohammad, BI; Yousif, NG | 1 |
1 review(s) available for d-alpha tocopherol and telmisartan
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for d-alpha tocopherol and telmisartan
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Vitamin E and telmisartan attenuates doxorubicin induced cardiac injury in rat through down regulation of inflammatory response.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Benzimidazoles; Benzoates; Blotting, Western; Cardiac Catheterization; Catalase; Chemokine CCL2; Creatine Kinase, MB Form; Disease Models, Animal; Down-Regulation; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Heart Diseases; Inflammation Mediators; Intercellular Adhesion Molecule-1; L-Lactate Dehydrogenase; Macrophages; Male; Malondialdehyde; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Telmisartan; Time Factors; Troponin I; Ventricular Function, Left; Vitamin E | 2012 |